Company intelligence / Profile preview

He Yi Tang

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

He Yi Tang is a Chinese pharmaceutical company primarily focused on the development, manufacturing, and distribution of Traditional Chinese Medicine (TCM) and modern pharmaceutical products. The company operates with a focus on integrating traditional herbal wisdom with contemporary manufacturing standards to treat a variety of chronic and acute conditions. Its product portfolio typically includes treatments for gastrointestinal health, respiratory ailments, and general wellness. He Yi Tang maintains a significant presence in the domestic Chinese market through both retail pharmacy chains and hospital supply channels.

Therapeutic areas: CardiovascularPulmonologyGastroenterology
Modalities: Small moleculeHerbal extract
Industry: Biotech

Beyond the preview

Go deeper on He Yi Tang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on He Yi Tang.

Explore the full profile